Validation of the Clinical Treatment Score post 5 years (CTS5) in women with hormone receptor positive, HER2-negative, node-negative disease from the TAILORx study
Authors
Sestak, I; Crager, M; Cuzick, J; Dowsett, M; Shak, S; Tang, G; Gray, R; Sparano, JCollections
- Centre for Cancer Prevention [1098]